Total Payments
$1.1M
2024 Payments
$210,691
Companies
17
Transactions
2,083
Medicare Patients
382
Medicare Billing
$32,109
Payment Breakdown by Category
Other$883,915 (77.0%)
Travel$147,494 (12.9%)
Consulting$59,213 (5.2%)
Food & Beverage$56,919 (5.0%)
Education$138.64 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $855,276 | 310 | 74.5% |
| Travel and Lodging | $147,494 | 616 | 12.9% |
| Consulting Fee | $59,213 | 23 | 5.2% |
| Food and Beverage | $56,919 | 1,110 | 5.0% |
| Grant | $28,640 | 12 | 2.5% |
| Education | $138.64 | 12 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $498,397 | 958 | $0 (2024) |
| ViiV Healthcare Company | $438,326 | 699 | $0 (2024) |
| Janssen Products, LP | $161,220 | 184 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $30,320 | 29 | $0 (2023) |
| Merck Sharp & Dohme LLC | $11,990 | 61 | $0 (2024) |
| Theratechnologies Inc. | $3,179 | 17 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,193 | 11 | $0 (2023) |
| Janssen Biotech, Inc. | $1,170 | 74 | $0 (2023) |
| EMD Serono, Inc. | $600.03 | 23 | $0 (2024) |
| ABBVIE INC. | $572.88 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $210,691 | 318 | ViiV Healthcare Company ($121,243) |
| 2023 | $195,895 | 332 | ViiV Healthcare Company ($120,461) |
| 2022 | $98,247 | 184 | ViiV Healthcare Company ($62,570) |
| 2021 | $83,405 | 159 | ViiV Healthcare Company ($38,200) |
| 2020 | $56,401 | 91 | Gilead Sciences, Inc. ($33,173) |
| 2019 | $203,516 | 413 | Gilead Sciences, Inc. ($120,071) |
| 2018 | $160,379 | 327 | Gilead Sciences, Inc. ($91,916) |
| 2017 | $139,149 | 259 | Janssen Products, LP ($79,677) |
All Payment Transactions
2,083 individual payment records from CMS Open Payments — Page 1 of 84
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Travel and Lodging | In-kind items and services | $817.95 | General |
| Category: HIV | ||||||
| 12/12/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Travel and Lodging | In-kind items and services | $288.17 | General |
| Category: HIV | ||||||
| 12/12/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $102.20 | General |
| Category: HIV | ||||||
| 12/11/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $590.00 | General |
| Category: HIV | ||||||
| 12/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $124.86 | General |
| 12/05/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Travel and Lodging | Cash or cash equivalent | $144.65 | General |
| Category: HIV | ||||||
| 12/05/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | Cash or cash equivalent | $120.68 | General |
| Category: HIV | ||||||
| 12/03/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: HIV | ||||||
| 12/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $107.20 | General |
| 11/27/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 11/27/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 11/27/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Travel and Lodging | Cash or cash equivalent | $145.89 | General |
| Category: HIV | ||||||
| 11/27/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Travel and Lodging | Cash or cash equivalent | $40.60 | General |
| Category: HIV | ||||||
| 11/27/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | Cash or cash equivalent | $30.08 | General |
| Category: HIV | ||||||
| 11/25/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: HIV | ||||||
| 11/20/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 11/20/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 11/19/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Travel and Lodging | Cash or cash equivalent | $181.38 | General |
| Category: HIV | ||||||
| 11/19/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Travel and Lodging | Cash or cash equivalent | $170.15 | General |
| Category: HIV | ||||||
| 11/19/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Travel and Lodging | Cash or cash equivalent | $169.61 | General |
| Category: HIV | ||||||
| 11/19/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | Cash or cash equivalent | $78.67 | General |
| Category: HIV | ||||||
| 11/19/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: HIV | ||||||
| 11/18/2024 | ViiV Healthcare Company | CABENUVA (Biological), DOVATO | Food and Beverage | In-kind items and services | $98.89 | General |
| Category: HIV | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.30 | General |
| 11/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.38 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 229 | 353 | $52,749 | $17,442 |
| 2022 | 3 | 56 | 87 | $12,120 | $4,153 |
| 2021 | 3 | 52 | 130 | $12,340 | $7,010 |
| 2020 | 3 | 45 | 83 | $7,910 | $3,504 |
Total Patients
382
Total Services
653
Medicare Billing
$32,109
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 106 | $26,838 | $9,511 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $10,532 | $2,695 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 48 | $8,588 | $2,585 | 30.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 60 | 115 | $2,300 | $966.00 | 42.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 12 | $1,896 | $856.38 | 45.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 17 | $1,700 | $514.14 | 30.2% |
| 90471 | Administration of vaccine | Office | 2023 | 15 | 23 | $896.26 | $313.71 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 36 | $8,262 | $2,889 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 22 | $3,348 | $1,178 | 35.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 18 | 29 | $510.00 | $85.86 | 16.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 66 | $9,900 | $5,729 | 57.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 20 | $2,000 | $1,149 | 57.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 18 | 44 | $440.00 | $132.00 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 39 | $5,850 | $2,736 | 46.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 18 | $1,800 | $690.70 | 38.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 15 | 26 | $260.00 | $77.40 | 29.8% |
About Dr. Michael Sension, MD
Dr. Michael Sension, MD is a Internal Medicine healthcare provider based in Fort Lauderdale, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790749661.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Sension, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $210,691 received in 2024. These payments were reported across 2,083 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($855,276).
As a Medicare-enrolled provider, Sension has provided services to 382 Medicare beneficiaries, totaling 653 services with total Medicare billing of $32,109. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Fort Lauderdale, FL
- Active Since 04/17/2006
- Last Updated 03/14/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1790749661
Products in Payments
- RUKOBIA (Drug) $227,916
- Biktarvy (Drug) $227,834
- DOVATO (Drug) $167,671
- Descovy (Drug) $117,960
- PREZCOBIX (Drug) $67,089
- Genvoya (Drug) $34,037
- Symtuza (Drug) $30,616
- Sunlenca (Drug) $8,693
- TRIUMEQ (Drug) $6,114
- JULUCA (Drug) $4,416
- Odefsey (Drug) $3,606
- EGRIFTA (Drug) $3,103
- CABENUVA (Biological) $1,883
- TIVICAY (Drug) $1,235
- APRETUDE (Biological) $966.77
- ISENTRESS (Drug) $767.70
- PIFELTRO (Drug) $658.78
- PIPELINE (Device) $413.27
- Mavyret (Drug) $284.17
- Truvada (Drug) $244.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fort Lauderdale
Keith Rubin, M.d, M.D
Internal Medicine — Payments: $2.0M
Internal Medicine $2.0M
Bernard Garcia, Md, MD
Internal Medicine — Payments: $499,841
Internal Medicine $499,841
Sheetal Sharma, Md, MD
Internal Medicine — Payments: $272,407
Internal Medicine $272,407
Joshua Lenchus, Do, DO
Internal Medicine — Payments: $82,782
Internal Medicine $82,782
Alan Graff, Md, MD
Internal Medicine — Payments: $29,238
Internal Medicine $29,238
Maxine Hamilton, Md, MD
Internal Medicine — Payments: $27,993
Internal Medicine $27,993